Motus GI (NASDAQ:MOTS) Shares Down 4.3%

Motus GI Holdings, Inc. (NASDAQ:MOTS) shares were down 4.3% during trading on Monday . The company traded as low as $0.45 and last traded at $0.46. Approximately 175,521 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 1,785,427 shares. The stock had previously closed at $0.48.

Motus GI Stock Performance

The stock’s 50-day moving average is $0.71 and its 200 day moving average is $3.38. The firm has a market cap of $2.09 million, a P/E ratio of -0.02 and a beta of 1.34. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.69 and a current ratio of 1.76.

Hedge Funds Weigh In On Motus GI

A number of large investors have recently added to or reduced their stakes in the company. Virtu Financial LLC increased its holdings in Motus GI by 245.3% during the 4th quarter. Virtu Financial LLC now owns 46,810 shares of the company’s stock worth $39,000 after purchasing an additional 33,254 shares in the last quarter. Millennium Management LLC bought a new position in Motus GI during the 4th quarter worth about $31,000. Renaissance Technologies LLC increased its holdings in Motus GI by 73.5% during the 2nd quarter. Renaissance Technologies LLC now owns 127,500 shares of the company’s stock worth $36,000 after purchasing an additional 54,000 shares in the last quarter. Vanguard Group Inc. bought a new position in Motus GI during the 3rd quarter worth about $43,000. Finally, Armistice Capital LLC increased its holdings in Motus GI by 107.7% during the 3rd quarter. Armistice Capital LLC now owns 567,000 shares of the company’s stock worth $255,000 after purchasing an additional 294,012 shares in the last quarter. Institutional investors own 20.06% of the company’s stock.

About Motus GI

Motus GI Holdings, Inc operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp.